Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Plus Therapeutics Inc (NQ: PSTV ) 2.140 -0.020 (-0.93%) Streaming Delayed Price Updated: 4:00 PM EDT, May 24, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 7,988 Open 2.130 Bid (Size) 2.100 (7) Ask (Size) 2.140 (6) Prev. Close 2.160 Today's Range 2.060 - 2.160 52wk Range 0.9694 - 3.210 Shares Outstanding 2,879,620 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News PSTV Stock Earnings: Plus Therapeutics Beats EPS, Misses Revenue for Q1 2024 May 15, 2024 PSTV stock results show that Plus Therapeutics beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024. Via InvestorPlace Micro-Cap Brain Cancer Focused Plus Therapeutics Poised To Receive $3M From US Department of Defense April 22, 2024 Plus Therapeutics will secure $3 million in funding from the Department of Defense for pediatric brain cancer trial expansion. Via Benzinga Performance YTD +15.68% +15.68% 1 Month +33.75% +33.75% 3 Month +13.83% +13.83% 6 Month +31.29% +31.29% 1 Year -29.61% -29.61% More News Read More PSTV Stock Earnings: Plus Therapeutics Beats EPS, Beats Revenue for Q4 2023 March 05, 2024 Via InvestorPlace Recap: Plus Therapeutics Q4 Earnings March 05, 2024 Via Benzinga 12 Health Care Stocks Moving In Monday's Intraday Session November 20, 2023 Via Benzinga Insiders Buying Plus Therapeutics And 2 Other Stocks Under $2 November 09, 2023 Via Benzinga Topics Stocks Exposures US Equities Why Plus Therapeutics Stock Popped Today November 01, 2023 Via Benzinga Earnings Outlook For Plus Therapeutics October 30, 2023 Via Benzinga Earnings Scheduled For March 5, 2024 March 05, 2024 Via Benzinga Plus Therapeutics Earnings Preview March 04, 2024 Via Benzinga Why Extreme Networks Shares Are Trading Lower By Around 15%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session November 01, 2023 Via Benzinga Why Plus Therapeutics Shares Are Trading Higher By Over 11%; Here Are 20 Stocks Moving Premarket November 01, 2023 Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday November 01, 2023 Via InvestorPlace 12 Health Care Stocks Moving In Tuesday's After-Market Session October 31, 2023 Via Benzinga Why Is Liquid Biopsy Firm Biocept Stock Trading Lower Today? October 16, 2023 Via Benzinga Topics Bankruptcy Exposures Financial Legal 12 Health Care Stocks Moving In Friday's After-Market Session September 29, 2023 Via Benzinga Earnings Scheduled For October 31, 2023 October 31, 2023 Via Benzinga Plus Therapeutics And 2 Other Stocks Under $2 Insiders Are Buying September 18, 2023 Via Benzinga Topics Stocks Exposures US Equities Why Avantax Shares Are Trading Higher By Over 27%? Here Are Other Stocks Moving In Monday's Mid-Day Session September 11, 2023 Via Benzinga 12 Health Care Stocks Moving In Monday's Pre-Market Session September 11, 2023 Via Benzinga 12 Health Care Stocks Moving In Friday's Intraday Session September 08, 2023 Via Benzinga Why Is Cancer Diagnostic Focused Biocept Stock Trading Higher Today? September 08, 2023 Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday September 08, 2023 Via InvestorPlace EXCLUSIVE: Cancer Firm Plus Therapeutics Licenses Diagnostic Assay To Detect Central Nervous System Cancers September 08, 2023 Via Benzinga Plus Therapeutics Presents Exciting New Clinical Data At Top Cancer Conference August 14, 2023 Via Benzinga Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
